BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7813119)

  • 1. Possible mechanisms involved in the natriuretic response to atrial natriuretic factor (ANF) and proANF 31-67 in the rat.
    Dietz JR; Vesely DL; Nazian SJ
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):599-606. PubMed ID: 7813119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of proANF-(31--67) on sodium excretion in conscious monkeys.
    Benjamin BA; Peterson TV
    Am J Physiol; 1995 Dec; 269(6 Pt 2):R1351-5. PubMed ID: 8594937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans.
    Vesely DL; Douglass MA; Dietz JR; Gower WR; McCormick MT; Rodriguez-Paz G; Schocken DD
    Circulation; 1994 Sep; 90(3):1129-40. PubMed ID: 8087923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three peptides from the ANF prohormone NH(2)-terminus are natriuretic and/or kaliuretic.
    Martin DR; Pevahouse JB; Trigg DJ; Vesely DL; Buerkert JE
    Am J Physiol; 1990 May; 258(5 Pt 2):F1401-8. PubMed ID: 2140017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of renal effects of atrial natriuretic factor during rat pregnancy.
    Omer S; Mulay S; Cernacek P; Varma DR
    Am J Physiol; 1995 Mar; 268(3 Pt 2):F416-22. PubMed ID: 7900841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal and systemic effects of synthetic atrial natriuretic factor.
    Seymour AA; Blaine EH; Mazack EK; Smith SG; Stabilito II; Haley AB; Napier MA; Whinnery MA; Nutt RF
    Life Sci; 1985 Jan; 36(1):33-44. PubMed ID: 2981380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to atrial natriuretic peptide, endopeptidase 24.11 inhibitor and C-ANP receptor ligand in the rat.
    Wilkins MR; Settle SL; Kirk JE; Taylor SA; Moore KP; Unwin RJ
    Br J Pharmacol; 1992 Sep; 107(1):50-7. PubMed ID: 1330165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged low dose infusion of atrial natriuretic factor in essential hypertension.
    Cusson JR; Thibault G; Cantin M; Larochelle P
    Clin Exp Hypertens A; 1990; 12(1):111-35. PubMed ID: 2155074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretion and renal effects of ANF prohormone peptides.
    Dietz JR; Vesely DL; Gower WR; Nazian SJ
    Clin Exp Pharmacol Physiol; 1995 Feb; 22(2):115-20. PubMed ID: 7621603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cGMP-phosphodiesterase restores the glomerular effects of atrial natriuretic factor in low sodium diet rats.
    Kalinowski L; Szczepanska-Konkel M; Pawelczyk T; Bizon D; Angielski S
    Ren Physiol Biochem; 1995; 18(5):254-66. PubMed ID: 8869083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.
    Beland B; Tuchelt H; Bähr V; Oelkers W
    J Clin Endocrinol Metab; 1994 Jul; 79(1):183-8. PubMed ID: 8027224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of cGMP in response to atrial natriuretic peptide in dogs with acute pancreatitis.
    Levy M; Cernacek P
    Can J Physiol Pharmacol; 1990 Jun; 68(6):663-6. PubMed ID: 2164870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic factor induces natriuresis during pacing tachycardia in dogs.
    Christensen G; Bugge JF; Ilebekk A; Kiil F
    Am J Physiol; 1989 Jun; 256(6 Pt 2):R1245-9. PubMed ID: 2525348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides from the N-terminus of the atrial natriuretic factor prohormone enhance guanylate cyclase activity and increase cyclic GMP levels in a wide variety of tissues.
    Vesely DL
    Mol Cell Biochem; 1992 Jan; 109(1):43-50. PubMed ID: 1352037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal effects of atrial natriuretic factor (99-126) in conscious sodium-replete sheep.
    Yates NA; McDougall JG; Coghlan JP; Coker AR; Gibson AP; Scoggins BA
    Clin Exp Pharmacol Physiol; 1988 Jul; 15(7):551-62. PubMed ID: 2978747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence supporting a physiological role for proANP-(1-30) in the regulation of renal excretion.
    Dietz JR; Scott DY; Landon CS; Nazian SJ
    Am J Physiol Regul Integr Comp Physiol; 2001 May; 280(5):R1510-7. PubMed ID: 11294776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ANF infusion on the renal responses to lower-body negative pressure in humans.
    Mauran P; Pham I; Sediame S; Jolly D; Chabrier PE; Carayon A; Andrivet P; Adnot S
    J Cardiovasc Pharmacol; 1998 May; 31(5):669-76. PubMed ID: 9593065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.